Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease

Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease

Utilization of the adaptive immune system against malignancies, both by immune-based therapies to activate T cells in vivo to attack cancer and by T-cell therapies to transfer effector cytolytic T lymphocytes (CTL) to the cancer patient, represent major novel therapeutic advancements in oncologic th...

Full description

Bibliographic Details
Main Authors: Natalia M. Tijaro-Ovalle, Theodoros Karantanos, Hong-Tao Wang, Vassiliki A. Boussiotis
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Immunology
Subjects:
T cells
antigen presenting cells (APCs)
GVHD
metabolism
GVL
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.00295/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.00295/full

Similar Items